ARTANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Artane, and when can generic versions of Artane launch?
Artane is a drug marketed by Lederle and is included in two NDAs.
The generic ingredient in ARTANE is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Artane
A generic version of ARTANE was approved as trihexyphenidyl hydrochloride by WATSON LABS on December 31st, 1969.
Summary for ARTANE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Clinical Trials: | 2 |
Patent Applications: | 1,912 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ARTANE at DailyMed |
Recent Clinical Trials for ARTANE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Shanghai Mental Health Center | Early Phase 1 |
University of Florida | |
Bachmann Strauss Dystonia & Parkinson Foundation, Inc. |
Anatomical Therapeutic Chemical (ATC) Classes for ARTANE
US Patents and Regulatory Information for ARTANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lederle | ARTANE | trihexyphenidyl hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 006773-010 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lederle | ARTANE | trihexyphenidyl hydrochloride | TABLET;ORAL | 006773-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lederle | ARTANE | trihexyphenidyl hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 012947-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |